Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk’s oral semaglutide. (Novo Nordisk/FDA) Americans now have access to the pill form of weight loss medication Wegovy, ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA-approved Wegovy pill is now available for those looking to lose weight. The Wegovy pill was FDA-approved just last month ...

Novo Nordisk’s wildly successful obesity medicine is now available as a pill, making it the first GLP-1 pill for weight loss in the United States. The pill is available in four doses and is cheaper ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week and could change obesity care. Here’s how the Wegovy pill works, who qualifies, how to take it, side effects, cost, and what this ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s better-regulated drugs on the market.

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

Weight-loss drug Wegovy is now available in the form of a pill in the United States, the Scandinavian drug-maker Novo Nordisk announced on Monday, Jan. 5. The first-of-its kind pill offers 1.5 and 4 ...

BBB shares tips for spotting misleading weight loss ads and avoiding costly subscription traps before you buy.

New oral medications could soon change how patients approach medical weight loss, offering an alternative to injectable treatments that have become increasingly common in recent years. In this week’s ...